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swelling and inflammatory infiltrates4 as the
patient did not complain of back pain or
radiculopathy, and his EMG and conduction
studies were normal.
We were successful in the identification of
Sphingomonas paucimobilis gene sequences
from our patient’s muscle DNA.
Sphingomonas paucimobilis (formerly
Pseudomonas paucimobilis) is a strictly aero-
bic, gram negative bacillus that is widely
distributed in water and soil. This micro-
organism is responsible for a variety of
community acquired and nosocomial infec-
tions5 but, to our knowledge, there are no
clinical reports of skeletal muscle infection
in the literature. The origin of the infection
could not be established in our patient: he
was not immunocompromised or debili-
tated, and had no history of recent wounds.
It may be that Sphinogomonas paucimobilis
acted as an opportunistic pathogen given the
mild upper respiratory tract infection that
preceded the onset of muscle pain and that
may have been responsible for a mild
decrease in immunological defences.
Infection with Sphinogomonas paucimobilis
appears to have limited inherent virulence
and no deaths related to this entity have
been reported in the literature. Thus the
benign disease course in this patient may
have been a result of the combination of the
limited virulence of Sphingomonas paucimobi-
lis itself, the antibiotic treatment and the
short course of prednisone he had received.
Unfortunately, we did not culture the
patient’s muscle biopsy to isolate causative
bacteria, and thus we cannot be conclusive
about the aetiopathological role of
Sphingomonas paucimobilis in localised myo-
sitis. However, the possibility of contamina-
tion either during biopsy or in the procedure
of DNA extraction and analyses is unlike
because of the strictly aseptic sterile techni-
ques we routinely use. Moreover, if contam-
ination were the cause, more common
bacterial sequences should have been identi-
fied.
At this point, a casual conclusive relation-
ship between the observed Sphingomonas
paucimobilis genome and myositis remains
to be demonstrated. However, we do feel
that the aetiopathogenesis of localised myo-
sitis is heterogeneous, and although uncom-
mon, Sphinogomonas paucimobilis infection
must be considered in the differential
diagnosis of patients presenting with focal
inflammatory muscle disease.
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Fragile X premutation presenting
as essential tremor
Essential tremor (ET) is one of the most
common movement disorders seen in rou-
tine neurological practice, but other diseases
may mimic this condition. Here we describe
a 62-year-old right-handed man with an
action (kinetic) tremor fulfilling diagnostic
criteria for ET which was the presenting
feature of the fragile X associated tremor/
ataxia syndrome. His sister’s grandchildren
were the clue to the diagnosis, illustrating
the importance of a detailed medical history
in descendents as well as ancestors in the
context of late onset neurological disorders.
ET, typically a symmetric bilateral pos-
tural tremor with fluctuating amplitude, can
be asymmetric and varies both in severity
and functional impact. It classically begins
in the fourth and fifth decades of life, is
frequently associated with a family history
and affects 0.8/1000 (95% confidence inter-
val 0.5 to 1) of the general population, with
a prevalence that increases with age.1 ET is
one of the most common movement dis-
orders seen in routine neurological practice,
and the diagnosis is usually straightforward.
The challenge is to recognise often subtle
features that point towards an alternative
cause of the tremor, which can have
important implications for treatment, prog-
nosis and genetic counselling. The fragile X
associated tremor/ataxia syndrome (FXTAS)
is one recently described disorder that enters
the differential diagnosis of ET.2 3 In this
video case report, we show the features of
FXTAS which may lead to a possible
diagnosis of ET, demonstrate that additional
often subtle clues point towards an under-
lying genetic cause and emphasise the
importance of thorough history taking.
CASE REPORT
A 62-year-old right-handed man presented
with an action (kinetic) tremor initially
affecting his left hand. This progressed over
5 years to involve both his hands and legs,
interfering with writing and fine motor
activities. Alcohol had no effect on the
tremor. He complained of being unsteady
but denied any falls or slowing of move-
ment. His medical history was significant
for ischaemic heart disease and previous
myocardial infarction. There was no family
history of tremor or movement disorder. His
sister’s grandson has fragile X syndrome,
and the case described here was found to
carry an unmethylated expansion within the
premutation range of the FMR1 gene
through cascade screening 7 years ago (88
repeats). There was no history of a neuro-
logical disorder or premature ovarian failure
in the female carriers. Two months after this
man’s result was reported, his own grandson
was shown to have fragile X syndrome.
Neurological examination revealed a bilat-
eral postural tremor more evident on the left
than the right, and a 4–6 Hz intention
tremor with finger-to-nose testing.
Handwriting was large but legible. The
tremor interfered with his ability to draw
an Archimedes spiral and led to corrugations
of a straight line drawn on the page.
Examination of the cranial nerves showed
subtle facial masking, mild dysarthria but no
Figure 2 Slow tau inversion recovery MRI of the upper third of the patient’s legs. (A, B) Diffuse
hyperintensity of the medial head of the gastrocnemius. (C, D) Normalised picture 10 months later.
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rigidity. Nystagmus was evident on extreme
lateral gaze only. He had bilateral pes cavus
and was areflexic. Tandem gait was
impaired. Romberg’s test was negative (see
video, available online).
Preliminary investigations, including rou-
tine bloods, thyroid function tests and nerve
conduction studies were within normal
limits. Formal cognitive testing was within
normal limits (Addenbrooke’s cognitive
examination score 97/100, Mini-Mental
State Examination (MMSE) 28/30). MRI of
the brain revealed generalised atrophy, par-
ticularly affecting the frontal lobes and
cerebellum, with characteristic low signal
in the middle cerebellar peduncles on T1 and
high signal on T2 sequences (fig 1).
DISCUSSION
Clinically, the patient fulfilled the diagnostic
criteria for ET,4 and given the prevalence of
ET, could the association with ET simply be
a chance finding? The patient described here
also had the classical clinical and imaging
features of FXTAS, with a postural tremor
developing in mid-adult life, high signal in
the middle cerebellar peduncle on MRI and
an unmethylated expansion within the
premutation range of the FMR1 gene. He
therefore shares core features with other
patients with FXTAS, falling within the
‘‘probable’’ FXTAS group in recent proposed
diagnostic criteria.3 It is therefore highly
likely that his movement disorder is due to
the FMR1 expansion. The gait ataxia, mild
dysarthria and areflexia are subtle clinical
clues that the diagnosis was not ET.
Subsequent neurophysiological studies were
within normal limits. All of these features
have been described in FXTAS,3 and point
away from ET as the diagnosis. The normal
Addenbrooke’s cognitive profile and MMSE
highlight the relative insensitivity of these
tests to frontal/subcortical deficits.
This case highlights the importance
of considering FXTAS in cases of ET,
particularly if there are atypical features,
and stresses the value of taking a detailed
family history, even though neurodevelop-
mental difficulties in the grandchildren or
nephews may not appear to be relevant.
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Figure 1 (A) MRI of the brain. Coronal section through the anterior limit of the putamen showing
generalised atrophy, particularly affecting the frontal lobes. (B) T2 MRI of the brain (axial section)
revealing cerebellar atrophy with characteristic high signal in the middle cerebellar peduncles.
PostScript
1196 J Neurol Neurosurg Psychiatry October 2008 Vol 79 No 10
 group.bmj.com on June 21, 2010 - Published by jnnp.bmj.comDownloaded from 
